Mesenchymal Stem/Stromal Cells: MESENCURE: A PROFESSIONALIZED CELL THERAPY FOR ARDS REDUCED THE MORTALITY OF SEVERE COVID-19 PATIENTS BY 68% ACCORDING TO A RECENTLY CONCLUDED MULTI-CENTER, CONTROLLED PHASE II STUDY

Detalles Bibliográficos
Autores principales: Bronshtein, T., David, D. Ben, Novak, A., Kivity, V., Hayek, T., Rozen, N., Meretzki, S., Hamoud, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2022
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035762/
http://dx.doi.org/10.1016/S1465-3249(22)00134-7

Ejemplares similares

Ejemplares similares